Publications by authors named "H Komoriyama"

Background: Because it is unclear whether implantable cardioverter-defibrillators (ICDs) are equally effective in patients of all ages, we investigated the association of age with long-term clinical outcomes of patients who underwent ICD implantation.

Methods And Results: A total of 416 consecutive patients (mean age: 69 years) from 4 tertiary hospitals who underwent ICD implantation or were upgraded from an existing permanent pacemaker between January 2011 and November 2022 were enrolled and divided into 3 groups based on age: <65 years (n=158), 65-74 years (n=138), and ≥75 years (n=120). We compared the incidence of all-cause death and adverse cardiovascular events, including cardiac death, appropriate ICD therapy, and heart failure hospitalization.

View Article and Find Full Text PDF
Article Synopsis
  • Researchers aimed to create a machine learning tool to automatically assess frailty in elderly heart failure patients, addressing the inconsistency of subjective frailty scales.
  • The study involved 417 patients aged 75 and older, using smartphone technology to analyze body motion and determine frailty scores based on key physical features.
  • Results showed that the machine learning model demonstrated strong agreement with actual frailty assessments and that higher frailty scores predicted an increased risk of death over a follow-up period.
View Article and Find Full Text PDF
Article Synopsis
  • - The study investigated the link between long-term cardiac troponin levels and adverse events in patients with cardiac sarcoidosis who were treated with prednisolone, involving 63 patients and 463 troponin measurements over about 30 months.
  • - Results indicated that a higher cumulative level of troponin over time correlated with a greater risk of serious heart-related issues, such as ventricular tachycardia or sudden cardiac death, occurring in about 19% of patients.
  • - The findings suggest that monitoring troponin levels regularly could help identify patients at higher risk for adverse cardiac events, indicating its potential value in clinical settings.
View Article and Find Full Text PDF